Skip to main content
. 2011 Apr-Jun;15(2):109–115.

Table 1. Overview of randomized controlled studies investigating the effects of Epo in patients with acute myocardial infarction.

graphic file with name hippokratia-15-113-i001.jpg

Main characteristics of the largest randomized controlled studies testing the effects of Epo administration in patients with acute myocardial infarction. CK, creatine-kinase; cTn, cardiac troponin; Epo, erythropoietin; IU, international units; IV, intravenous; LV, left ventricular; MR, magnetic resonance; PCI, percutaneous coronary intervention; STEMI, ST-elevation myocardial infarction, Reproduced from: Andreotti F, Agati L, Conti E, Santucci E, Rio T, Tarantino F, et al. Update on phase II studies of erythropoietin in acute myocardial infarction. Rationale and design of Exogenous erythropoietin in Acute Myocardial Infarction: New Outlook aNd Dose Association Study (EPAMINONDAS)